Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Friday, October 30, 2026
earnings report
October 30, 2026
Q3 2026
Est. EPS: $16.06
Actual EPS: $14.29
EPS surprise: 40.69%
Company overview
Market Cap$82.0B
PriceUSD 796.88
P/E19.69
EPS (TTM)40.46
52-week high859.34
52-week low572.75
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410